Akshaya C. Murugesan

Madurai, TN 625002, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development.

Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development.

Journal: Frontiers in endocrinology
Published: June 22, 2026

Preclinical validation of tetrahydroquinoline derivatives as EGFR inhibitor inducing glioblastoma cell death.

Preclinical validation of tetrahydroquinoline derivatives as EGFR inhibitor inducing glioblastoma cell death.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: January 22, 2026

Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality.

Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality.

Journal: The New England journal of medicine
Published: October 15, 2025

Graphitic carbon nitride nanoparticle: g-C3N4 synthesis, characterization, and its biological activity against glioblastoma.

Graphitic carbon nitride nanoparticle: g-C3N4 synthesis, characterization, and its biological activity against glioblastoma.

Journal: European journal of pharmacology
Published: May 14, 2025

Anti-GBM effects of polyphenolic extract from Avicennia marina.

Anti-GBM effects of polyphenolic extract from Avicennia marina.

Journal: Journal of ethnopharmacology
Published: April 24, 2025

Comparative analysis of the antiglioblastoma activity of adenosine A2A receptor and CK1δ blockers.

Comparative analysis of the antiglioblastoma activity of adenosine A2A receptor and CK1δ blockers.

Journal: European journal of pharmacology
Published: March 17, 2025

A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment.

A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: December 28, 2024

Novel tetrahydroquinoline derivatives induce ROS-mediated apoptosis in glioblastoma cells.

Novel tetrahydroquinoline derivatives induce ROS-mediated apoptosis in glioblastoma cells.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 12, 2024

Growth phase-dependent ribonucleic acid production dynamics.

Growth phase-dependent ribonucleic acid production dynamics.

Journal: International journal of biological macromolecules
Published: January 25, 2024

A dual fluorescence protein expression system detects cell cycle dependent protein noise.

A dual fluorescence protein expression system detects cell cycle dependent protein noise.

Journal: International journal of biological macromolecules
Published: December 20, 2023

Design, synthesis and anticancer evaluation of novel arylhydrazones of active methylene compounds.

Design, synthesis and anticancer evaluation of novel arylhydrazones of active methylene compounds.

Journal: International journal of biological macromolecules
Published: May 31, 2023

Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and Pharmacoprofiling.

Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and Pharmacoprofiling.

Journal: International journal of molecular sciences
Published: April 26, 2023
Showing 1-12 of 37

Last Updated: 09/26/2026